期刊文献+

糖皮质激素在临床上的准确认识与合理应用 被引量:28

The accurate comprehension and application of glucocorticoid
下载PDF
导出
摘要 从糖皮质激素(GC)的命名,其对糖、蛋白质、脂肪和水电解质代谢的影响及对心血管、消化、神经、血液、内分泌系统和皮肤的生理与病理作用进行了讨论。着重介绍了GC的基因组效应、非基因组效应和总效应,将GC划分为小剂量、中剂量、大剂量、超大剂量和冲击疗法的方法和依据;“反跳现象”、“虚弱征群”、“应激危象”等长期应用GC停药后易出现的不良反应及对策。还介绍了GC容易引起的十余种不良反应和预防手段。指出“无指征地使用超大剂量GC和冲击疗法”、“重视皮肤表现,忽视系统影响”、“治疗自身抗体”、“激素剂型选择不当”、“予以抗生素保驾”等临床上GC被不合理应用的现象。还介绍了新的GC替代物。最后就GC的治疗对象、治疗剂量进行了讨论。
作者 郑捷
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2005年第11期785-787,共3页 Journal of Clinical Dermatology
  • 相关文献

参考文献9

  • 1Buttgereit F, da Silva JA, Boers M, et al. Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology[J]. Ann Rheum Dis, 2002, 61(8): 718-722.
  • 2Galon J, Franchimont D, Hiroi N, et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells[J]. FASEB J, 2002. 16(1): 61-71.
  • 3陈虹,钟琦,薛峰,郑捷.地塞米松对小鼠脾脏巨噬细胞内TLR4和TLR2表达的影响[J].上海免疫学杂志,2003,23(2):91-94. 被引量:11
  • 4Primavera A, Audenino D, Mavilio N, et al. Reversible posterior leucoencephalopathy syndrome in systemic lupus and vasculitis[J].Ann Rheum Dis, 2001, 60(5): 534-537.
  • 5郑捷 许以平 郑捷.结缔组织疾病[A].许以平,郑捷.现代免疫学检验与临床实践[M].上海:上海科技文献出版社,1999.61-101.
  • 6金丽威,鲁智勇,郑捷.抗不同细胞核成分抗体与SLE病情活动不相关[J].中华皮肤科杂志,2004,37(9):509-511. 被引量:4
  • 7Futei Y, Amagai M, Ishii K, et al. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus[J]. J Dermatol Sci, 2001, 26(1): 55-61.
  • 8郑捷.个体化:天疱疮的治疗原则——以尽可能少的皮质类固醇治疗天疱疮[J].临床皮肤科杂志,2000,29(6):382-383. 被引量:22
  • 9Schacke H, Schottelius A, Docke WD, et al. Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects[J]. Proc Natl Acad Sci U S A, 2004, 101(1): 227-232.

二级参考文献21

  • 1谢红付,李吉,陈翔,施为,陈明亮,杜乾君.系统性红斑狼疮疾病活动性与ANA及dsDNA抗体水平相关性探讨[J].中华皮肤科杂志,2003,36(7):404-404. 被引量:3
  • 2Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum, 1992, 35: 630-640.
  • 3No authors listed. Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines.Arthritis Rheum, 1999, 42: 1785-1796.
  • 4Villalta D, Romelli PB, Savina C, et al. Anti-dsDNA antibody avidity determination by a simple reliable ELISA method for SLE diagnosis and monitoring. Lupus, 2003, 12: 31-36.
  • 5Schiffer LE, Hussain N, Wang X, et al. Lowering anti-dsDNA antibodies--what′s new? Lupus, 2002,11: 885-894.
  • 6Yee CS, Hussein H, Skan J, et al. Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus. Rheumatology (Oxford), 2003, 42: 276-279.
  • 7Muzio M, Polentarutti N, Bosisio D, et al. Toll-like receptors: a growing family of imraune receptors that are differentially expressed and regulated by different leukocytes[J]. J Leukoc Biol, 2000, 67:450.
  • 8Roger T, David J, Glauser MP, et al. MIF regulates innate immune responses through modulation of Toll-like receptor 4 [ J ] . Nature,2001,414(6866) :920.
  • 9Liu Y, Wang Y, Yamakuchi M, et al: Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation[J]. Infect Immun, 2001, 69:2788.
  • 10Hoshino K, Takeuchi O, Kawai T, et al. Cutting edge: Toll-like receptor 4(TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the LPS gene product[J] . J Immunol, 1999,162:3749.

共引文献34

同被引文献192

引证文献28

二级引证文献111

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部